header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

RANDOMISED CONTROLLED TRIAL OF CEMENTLESS AND CEMENTED PRESS-FIT CONDYLAR (PFC) TOTAL KNEE ARTHROPLASTY (TKA). A TEN-YEAR SURVIVAL ANALYSIS.



Abstract

Cementless fixation for total knee arthroplasty (TKA) has been proposed as an alternative to cemented for several reasons, of which the most important is the possibility of increased survival. The purpose of this study was to compare the ten-year survival of TKA in a unique prospective randomised trial of cemented versus cementless fixation.

A consecutive series of patients was randomised to undergo either cemented or cementless Press-Fit Condylar (PFC®) TKA. There were 219 patients (277 TKA) in the cemented group and 177 (224 TKA) in the cementless group. There were no significant differences in age, gender or diagnosis between the two groups.

A single surgeon (PJG) performed or directly supervised all operations. The prosthesis used in all cases was the posterior-cruciate-retaining PFC® knee replacement system. Independent clinical review was performed at six months, annually until five years, and finally at ten years after surgery. Using revision surgery as the end-point, logrank analysis was used to compare the ten-year survival of the two groups.

The mean interval of follow-up was 6.3 years (range, 2.0–11.7). At the last review, 104 patients (138 TKA) had died, without need for revision. All patients were traced and there was no loss to follow-up. In the cemented group, seven arthroplasties were revised; five for infection and two for exchange of polyethylene inserts. Ten-year survival was 96.5% (95% CI, 90.9–98.7%). In the cementless group, six arthroplasties were revised; three for aseptic loosening, one for infection, one for instability and one resizing for anterior knee pain. The ten-year survival was 96.6% (95% CI, 89.6–98.9%). There was no significant difference in the survival of the two groups.

The long-term survival of cementless PFC® TKA is not significantly different from their cemented counterparts. The use of less expensive cemented implants, therefore, can make a significant impact on health resource planning.

The abstracts were prepared by Mr Simon Donell. Correspondence should be addressed to him at the Department of Orthopaedics, Norfolk & Norwich Hospital, Level 4, Centre Block, Colney Lane, Norwich NR4 7UY, United Kingdom.